E. Khimova

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: first global report

A. Spanevello, R. Duarte, D. Visca, 2019, European Respiratory Journal.

Surveillance of adverse events in the treatment of drug-resistant tuberculosis: A global feasibility study.

A. Spanevello, R. Duarte, E. Martínez Robles, 2019, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases.

New regimens and new medications in the treatment of tuberculosis: keeping step?

G. Balasaniantc, D. Ruzanov, I. Buinevich, 2021, Clinical Microbiology and Antimicrobial Chemotherapy.

Urine biomarkers of pulmonary tuberculosis

F. Drobniewski, V. Nikolayevskyy, P. Eliseev, 2022, Expert review of respiratory medicine.

Outcome of treatment of MDR-TB or drug-resistant patients treated with bedaquiline and delamanid: Results from a large global cohort.

A. Spanevello, R. Duarte, E. Martínez Robles, 2021, Pulmonology.